Wasatch Advisors Inc Sangamo Therapeutics, Inc Transaction History

Wasatch Advisors Inc

  • $19 Billion
  • Q1 2024

A detailed history of Wasatch Advisors Inc transactions in Sangamo Therapeutics, Inc stock. As of the latest transaction made, Wasatch Advisors Inc holds 20,132,324 shares of SGMO stock, worth $9.06 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
20,132,324
Previous 12,397,924 62.38%
Holding current value
$9.06 Million
Previous $6.69 Million 101.49%
% of portfolio
0.07%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 18, 2024
BUY
$0.42 - $1.38 $3.25 Million - $10.7 Million
7,734,400 Added 62.38%
20,132,324 $13.5 Million
Q4 2023

Feb 14, 2024
SELL
$0.3 - $0.63 $1.68 Million - $3.52 Million
-5,588,857 Reduced 31.07%
12,397,924 $6.69 Million
Q3 2023

Nov 14, 2023
BUY
$0.58 - $1.47 $541,917 - $1.37 Million
934,341 Added 5.48%
17,986,781 $10.8 Million
Q2 2023

Aug 07, 2023
BUY
$1.11 - $1.74 $3.79 Million - $5.93 Million
3,410,023 Added 25.0%
17,052,440 $22.2 Million
Q1 2023

May 12, 2023
BUY
$1.66 - $3.67 $1.65 Million - $3.64 Million
991,663 Added 7.84%
13,642,417 $24 Million
Q4 2022

Feb 14, 2023
SELL
$2.77 - $5.07 $1.31 Million - $2.39 Million
-471,362 Reduced 3.59%
12,650,754 $39.7 Million
Q3 2022

Nov 14, 2022
BUY
$4.27 - $6.39 $3.12 Million - $4.66 Million
729,797 Added 5.89%
13,122,116 $64.3 Million
Q2 2022

Aug 12, 2022
BUY
$3.28 - $6.21 $5.95 Million - $11.3 Million
1,815,322 Added 17.16%
12,392,319 $51.3 Million
Q1 2022

May 13, 2022
SELL
$5.23 - $7.82 $2.01 Million - $3 Million
-383,985 Reduced 3.5%
10,576,997 $61.5 Million
Q4 2021

Feb 15, 2022
BUY
$7.29 - $10.97 $2.22 Million - $3.35 Million
304,940 Added 2.86%
10,960,982 $82.2 Million
Q3 2021

Nov 12, 2021
BUY
$9.01 - $12.01 $3.17 Million - $4.22 Million
351,747 Added 3.41%
10,656,042 $96 Million
Q2 2021

Aug 12, 2021
SELL
$10.17 - $12.64 $245,381 - $304,977
-24,128 Reduced 0.23%
10,304,295 $123 Million
Q1 2021

May 10, 2021
BUY
$10.88 - $17.05 $2.79 Million - $4.37 Million
256,042 Added 2.54%
10,328,423 $129 Million
Q4 2020

Feb 12, 2021
BUY
$9.23 - $18.18 $27.4 Million - $53.9 Million
2,963,446 Added 41.69%
10,072,381 $157 Million
Q3 2020

Nov 10, 2020
BUY
$9.38 - $12.48 $3.34 Million - $4.44 Million
355,792 Added 5.27%
7,108,935 $67.2 Million
Q2 2020

Aug 12, 2020
BUY
$6.21 - $11.83 $5.06 Million - $9.64 Million
814,709 Added 13.72%
6,753,143 $60.5 Million
Q1 2020

May 08, 2020
SELL
$5.05 - $8.85 $7.82 Million - $13.7 Million
-1,548,583 Reduced 20.68%
5,938,434 $37.8 Million
Q4 2019

Feb 13, 2020
BUY
$8.03 - $11.7 $4.73 Million - $6.89 Million
588,494 Added 8.53%
7,487,017 $62.7 Million
Q3 2019

Nov 14, 2019
BUY
$9.05 - $12.22 $2.71 Million - $3.66 Million
299,615 Added 4.54%
6,898,523 $62.4 Million
Q2 2019

Aug 07, 2019
BUY
$8.75 - $13.03 $1.41 Million - $2.1 Million
161,000 Added 2.5%
6,598,908 $0
Q1 2019

May 08, 2019
BUY
$7.72 - $12.81 $10.5 Million - $17.4 Million
1,359,170 Added 26.76%
6,437,908 $0
Q4 2018

Feb 14, 2019
BUY
$9.51 - $16.6 $5.08 Million - $8.87 Million
534,142 Added 11.75%
5,078,738 $58.3 Million
Q3 2018

Nov 07, 2018
BUY
$13.05 - $19.05 $6.35 Million - $9.27 Million
486,429 Added 11.99%
4,544,596 $0
Q2 2018

Aug 02, 2018
BUY
$13.9 - $19.8 $5.08 Million - $7.23 Million
365,186 Added 9.89%
4,058,167 $0
Q1 2018

May 02, 2018
SELL
$16.7 - $26.35 $16.8 Million - $26.5 Million
-1,005,530 Reduced 21.4%
3,692,981 $0
Q4 2017

Jan 16, 2018
SELL
$11.6 - $17.35 $5.71 Million - $8.54 Million
-492,278 Reduced 9.48%
4,698,511 $0
Q3 2017

Nov 08, 2017
SELL
$8.4 - $15.0 $14.6 Million - $26.1 Million
-1,739,746 Reduced 25.1%
5,190,789 $0
Q2 2017

Aug 16, 2017
BUY
N/A
6,930,535
6,930,535 $0

Others Institutions Holding SGMO

# of Institutions
138
Shares Held
100M
Call Options Held
35.5K
Put Options Held
65.8K
View Full List

About SANGAMO THERAPEUTICS, INC

SGMO Quotes by TradingView
  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $70.4M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track Wasatch Advisors Inc Portfolio

Follow Wasatch Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wasatch Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wasatch Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email